For patients with BD, neither the levels of Aβ-peptides nor ptau or tau were significantly different from the levels in the other diagnostic groups, except for significantly higher Aβ40 levels compared with SCZ (p=0.0288). The gene discussed is MAPT; the disease is Behcet disease.